Predictive Role of Circulating Angiogenic Factors for Second-line Paclitaxel and Ramucirumab.

NCT05301465 · clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

University of Pisa